| Serial Number | 98824432 |
| Word Mark | COLLAGE |
| Filing Date | Monday, October 28, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, June 17, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 2, 2025 |
| Goods and Services | Pharmaceutical research and development; scientific research and development; medical research and development in the field of medical preparations; pharmaceutical research and analysis services using machine learning analytics for drug efficacy and safety; technical consultation services and product development for others in the fields of biotechnology and pharmaceuticals; pharmaceutical and scientific research and development relating to RNA targeting and assay development; platform as a service (PaaS) featuring computer software platforms for performing drug discovery and development and biotechnology research; pharmaceutical drug development services related to proteins, ribosomes, RNA, and DNA |
| Goods and Services | Pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders; pharmaceutical preparations, namely, RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics; biopharmaceutical preparations and agents, namely, pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders, and RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 28, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 3, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Collage Bio Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Menlo Park, CA 94025 US |
| Party Name | Collage Bio Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Menlo Park, CA 94025 US |
| Event Date | Event Description |
| Monday, October 28, 2024 | NEW APPLICATION ENTERED |
| Sunday, April 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 29, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 8, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 8, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, May 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 7, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, August 7, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, November 3, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 4, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 2, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 2, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 27, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, June 17, 2026 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 17, 2026 | SOU EXTENSION 1 FILED |
| Wednesday, June 17, 2026 | SOU EXTENSION 1 GRANTED |
| Thursday, June 18, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |